YM-254890
YM-254890
YM-254890 is a naturally occurring cyclic depsipeptide that acts as a potent and selective inhibitor of the G_q protein. It was originally isolated from the culture broth of the bacterium Chromobacterium sp. QS3666. YM-254890 has garnered significant interest in the field of pharmacology due to its potential therapeutic applications in diseases where G_q signaling is implicated.
Chemical Structure
YM-254890 is characterized by its complex cyclic structure, which includes both peptide and ester linkages, classifying it as a depsipeptide. The molecule's unique configuration allows it to bind specifically to the G_q subunit, inhibiting its interaction with downstream effectors.
Mechanism of Action
YM-254890 exerts its effects by binding to the G_q protein, a member of the G protein family involved in transducing signals from G protein-coupled receptors (GPCRs) to intracellular pathways. By inhibiting G_q, YM-254890 effectively blocks the signaling cascade that leads to the activation of phospholipase C, thereby reducing the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). This inhibition can modulate various physiological processes, including smooth muscle contraction, platelet aggregation, and cell proliferation.
Potential Applications
The selective inhibition of G_q by YM-254890 presents potential therapeutic applications in conditions such as hypertension, heart failure, and certain types of cancer. By modulating G_q-mediated pathways, YM-254890 could offer a novel approach to treating diseases characterized by dysregulated G protein signaling.
Research and Development
Ongoing research is focused on understanding the full spectrum of YM-254890's biological effects and its potential as a lead compound for drug development. Studies are exploring its efficacy and safety in various animal models and its potential synergistic effects with other therapeutic agents.
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit.
- Tirzepatide starting from $45.00/week and up (dose dependent)
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
